{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:00:35Z","timestamp":1789012835341,"version":"build-2803163510"},"reference-count":26,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.1182\/bloodadvances.2023009876","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:23:20Z","timestamp":1687559000000},"page":"4966-4969","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B"],"prefix":"10.1182","volume":"7","author":[{"given":"Manfred","family":"Schmidt","sequence":"first","affiliation":[{"name":"1GeneWerk GmbH, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Foster","sequence":"additional","affiliation":[{"name":"2Barts Liver Centre, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-9062","authenticated-orcid":false,"given":"Michiel","family":"Coppens","sequence":"additional","affiliation":[{"name":"3Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"4Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Thomsen","sequence":"additional","affiliation":[{"name":"1GeneWerk GmbH, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Dolmetsch","sequence":"additional","affiliation":[{"name":"5uniQure Inc, Lexington, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Heijink","sequence":"additional","affiliation":[{"name":"6uniQure biopharma BV, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Monahan","sequence":"additional","affiliation":[{"name":"7CSL Behring, King of Prussia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-2089","authenticated-orcid":false,"given":"Steven W.","family":"Pipe","sequence":"additional","affiliation":[{"name":"8Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"2","key":"2023091115342323100_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ymthe.2020.10.018","article-title":"Liver injury increases the incidence of HCC following AAV gene therapy in mice","volume":"29","author":"Dalwadi","year":"2021","journal-title":"Mol Ther"},{"issue":"17","key":"2023091115342323100_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","article-title":"Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors","volume":"8","author":"Donsante","year":"2001","journal-title":"Gene Ther"},{"issue":"5837","key":"2023091115342323100_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"issue":"2","key":"2023091115342323100_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4149\/neo_2020_200730N785","article-title":"LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p\/14-3-3\u03b6\/TGF\u03b2R1 axis","volume":"68","author":"Lou","year":"2021","journal-title":"Neoplasma"},{"issue":"2","key":"2023091115342323100_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"2023091115342323100_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.omtn.2022.08.027","article-title":"Subgenomic particles in rAAV vectors result from DNA lesion\/break and non-homologous end joining of vector genomes","volume":"29","author":"Zhang","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"2023091115342323100_bib7","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/mt.2012.197","article-title":"Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity","volume":"20","author":"Rosas","year":"2012","journal-title":"Mol Ther"},{"issue":"12","key":"2023091115342323100_bib8","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood-2010-08-302729","article-title":"Assessing the potential for AAV vector genotoxicity in a murine model","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2023091115342323100_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2023091115342323100_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol Ther"},{"issue":"4","key":"2023091115342323100_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/mt.2016.47","article-title":"Wild-type AAV insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV","volume":"24","author":"Nault","year":"2016","journal-title":"Mol Ther"},{"issue":"10","key":"2023091115342323100_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","article-title":"Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas","volume":"47","author":"Nault","year":"2015","journal-title":"Nat Genet"},{"key":"2023091115342323100_bib13","doi-asserted-by":"crossref","first-page":"809118","DOI":"10.3389\/fmed.2021.809118","article-title":"Gene therapy advances: a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"2023091115342323100_bib14","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol Ther"},{"issue":"1","key":"2023091115342323100_bib15","doi-asserted-by":"crossref","first-page":"e2020069","DOI":"10.4084\/mjhid.2020.069","article-title":"Gene therapy for hemophilia: facts and quandaries in the 21st century","volume":"12","author":"Arruda","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2023091115342323100_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/asheducation-2010.1.191","article-title":"The aging patient with hemophilia: complications, comorbidities, and management issues","volume":"2010","author":"Philipp","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"2023091115342323100_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa2211644","article-title":"Gene therapy with etranacogene dezaparvovec for hemophilia B","volume":"388","author":"Pipe","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"19-20","key":"2023091115342323100_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/hum.2021.053","article-title":"Long-term follow-up of hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"32","author":"Bougn\u00e8res","year":"2021","journal-title":"Hum Gene Ther"},{"issue":"7","key":"2023091115342323100_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/104303401750148649","article-title":"Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples","volume":"12","author":"Schmidt","year":"2001","journal-title":"Hum Gene Ther"},{"key":"2023091115342323100_bib21","unstructured":"Debuire\n              B\n            , LemoineA. Liver: hepatocellular carcinoma. Atlas Genet Cytogenet Oncol Haematol. 2001. Accessed 3 July 2023. http:\/\/atlasgeneticsoncology.org\/solid-tumor\/5039\/liver-hepatocellular-carcinoma."},{"issue":"1","key":"2023091115342323100_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgw118","article-title":"Frequently mutated genes\/pathways and genomic instability as prevention targets in liver cancer","volume":"38","author":"Rao","year":"2017","journal-title":"Carcinogenesis"},{"issue":"6","key":"2023091115342323100_bib22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"2023091115342323100_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v11.i1.1","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review","volume":"11","author":"Desai","year":"2019","journal-title":"World J Hepatol"},{"issue":"5","key":"2023091115342323100_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.dld.2009.09.002","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal","volume":"42","author":"Trevisani","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"2","key":"2023091115342323100_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/hae.13668","article-title":"Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: a national inpatient sample study","volume":"25","author":"Thalappillil","year":"2019","journal-title":"Haemophilia"},{"issue":"1","key":"2023091115342323100_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2516.2010.02366.x","article-title":"Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia","volume":"17","author":"Ragni","year":"2011","journal-title":"Haemophilia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/17\/4966\/2076974\/blooda_adv-2023-009876-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/17\/4966\/2076974\/blooda_adv-2023-009876-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:34:41Z","timestamp":1694432081000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/17\/4966\/496497\/Molecular-evaluation-and-vector-integration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023009876","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]}}}